Craig Wheeler
Director/Board Member presso AMICUS THERAPEUTICS, INC.
Patrimonio netto: 616 919 $ in data 31/03/2024
Profilo
Craig A. Wheeler è un uomo d'affari che è stato al timone di 5 diverse aziende ed è nel consiglio di Amicus Therapeutics, Inc. In passato ha ricoperto la posizione di Senior Member-Health Care Practice presso The Boston Consulting Group, Inc., presidente di Avanir Pharmaceuticals, Inc., presidente, amministratore delegato e direttore di Momenta Pharmaceuticals, Inc., presidente di Chiron Corp., presidente di CHIRON Biopharmaceuticals, presidente di Association for Accessible Medicines e membro del Whitehead Institute for Biomedical Research. Il signor Wheeler ha conseguito una laurea e un diploma di laurea presso la Cornell University e un MBA presso la Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
08/06/2023 | 52 370 ( 0.02% ) | 616 919 $ | 31/03/2024 |
Posizioni attive di Craig Wheeler
Società | Posizione | Inizio |
---|---|---|
AMICUS THERAPEUTICS, INC. | Director/Board Member | 10/06/2016 |
Headwaters Biotech Advisors LLC | Chief Executive Officer | - |
Precedenti posizioni note di Craig Wheeler
Società | Posizione | Fine |
---|---|---|
MOMENTA PHARMACEUTICALS, INC. | Chief Executive Officer | 01/10/2020 |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Chairman | 22/02/2016 |
GEORGIA PUBLIC HEALTH ASSOCIATION, INC. | Chairman | 01/02/2016 |
AVANIR PHARMACEUTICALS INC | Chairman | 13/01/2015 |
CHIRON Biopharmaceuticals | President | 01/06/2006 |
Formazione di Craig Wheeler
Cornell University | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AMICUS THERAPEUTICS, INC. | Health Technology |
Aziende private | 9 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
CHIRON Biopharmaceuticals | |
Headwaters Biotech Advisors LLC | |
GEORGIA PUBLIC HEALTH ASSOCIATION, INC. |
- Borsa valori
- Insiders
- Craig Wheeler